Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

CT scans can find serious prostate cancer even when PSA levels are low.

Consider Castleman's disease in similar cases; histology and steroids help diagnose and manage it.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Acne is the most common skin problem in Brazil, with a need for improved dermatological care and health education, especially for the public sector and black-skinned individuals.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

Using finasteride with TIP extends time off period for prostate cancer patients.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

The review found that different stem cell types in the skin are crucial for repair and could help treat skin diseases and cancer.

Melanoma survivors are more likely to use sunscreen and seek shade than others, but less than half often use sunscreen and avoid the sun, and some still use tanning beds.

HPV-150 and HPV-151 are rare skin viruses linked to warts and some skin cancers.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Skin cancer is common in elderly nursing home residents, with risk factors including being male, having light skin, outdoor work history, and smoking. Regular skin checks are recommended.

Spironolactone does not increase cancer risk and may lower prostate cancer risk, but more research is needed.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Natural products may help treat Non-Small Cell Lung Cancer by causing cancer cell death through ferroptosis.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

SGK1 is important in cancer growth and treatment resistance, and targeting it could improve therapies.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Slovak breast cancer survivors have moderate quality of life, with emotional and cognitive strengths but social and physical challenges, needing targeted support.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.